Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 4
2010 8
2011 6
2012 4
2013 7
2014 7
2015 6
2016 21
2017 15
2018 6
2019 5
2020 9
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Chopra N, Tovey H, Pearson A, Cutts R, Toms C, Proszek P, Hubank M, Dowsett M, Dodson A, Daley F, Kriplani D, Gevensleben H, Davies HR, Degasperi A, Roylance R, Chan S, Tutt A, Skene A, Evans A, Bliss JM, Nik-Zainal S, Turner NC. Chopra N, et al. Among authors: gevensleben h. Nat Commun. 2020 May 29;11(1):2662. doi: 10.1038/s41467-020-16142-7. Nat Commun. 2020. PMID: 32471999 Free PMC article. Clinical Trial.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Turner NC, Kingston B, Kilburn LS, Kernaghan S, Wardley AM, Macpherson IR, Baird RD, Roylance R, Stephens P, Oikonomidou O, Braybrooke JP, Tuthill M, Abraham J, Winter MC, Bye H, Hubank M, Gevensleben H, Cutts R, Snowdon C, Rea D, Cameron D, Shaaban A, Randle K, Martin S, Wilkinson K, Moretti L, Bliss JM, Ring A. Turner NC, et al. Among authors: gevensleben h. Lancet Oncol. 2020 Oct;21(10):1296-1308. doi: 10.1016/S1470-2045(20)30444-7. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919527 Free PMC article. Clinical Trial.
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Sandhu SK, Schelman WR, Wilding G, Moreno V, Baird RD, Miranda S, Hylands L, Riisnaes R, Forster M, Omlin A, Kreischer N, Thway K, Gevensleben H, Sun L, Loughney J, Chatterjee M, Toniatti C, Carpenter CL, Iannone R, Kaye SB, de Bono JS, Wenham RM. Sandhu SK, et al. Among authors: gevensleben h. Lancet Oncol. 2013 Aug;14(9):882-92. doi: 10.1016/S1470-2045(13)70240-7. Epub 2013 Jun 28. Lancet Oncol. 2013. PMID: 23810788 Clinical Trial.
[Tonsillar lymphangiomatous polyp].
Kühnemund M, Wernert N, Gevensleben H, Gerstner AO. Kühnemund M, et al. Among authors: gevensleben h. HNO. 2010 Apr;58(4):409-12. doi: 10.1007/s00106-010-2083-0. HNO. 2010. PMID: 20336269 Review. German.
Histotype-specific analysis of acid ceramidase expression in ovarian cancer.
El-Balat A, Karn T, Holtrich U, Becker S, Kommoss S, Győrffy B, Anglesio MS, Huntsman DG, Drosos Z, Rody A, Gevensleben H, Hanker LC. El-Balat A, et al. Among authors: gevensleben h. Virchows Arch. 2020 Jun;476(6):855-862. doi: 10.1007/s00428-019-02728-0. Epub 2020 Jan 2. Virchows Arch. 2020. PMID: 31897818
Can neurophysiological markers of anticipation and attention predict ADHD severity and neurofeedback outcomes?
Aggensteiner PM, Albrecht B, Strehl U, Wörz S, Ruckes C, Freitag CM, Rothenberger A, Gevensleben H, Millenet S, Hohmann S, Banaschewski T, Legenbauer T, Holtmann M, Brandeis D. Aggensteiner PM, et al. Among authors: gevensleben h. Biol Psychol. 2021 Oct;165:108169. doi: 10.1016/j.biopsycho.2021.108169. Epub 2021 Aug 18. Biol Psychol. 2021. PMID: 34416347 Free article.
90 results